Skip to main content
Article thumbnail
Location of Repository

Stress echocardiogaphy: A useful test for assessing cardiac risk in diabetes

By Rajan Sharma and Denis Pellerin


Cardiovascular disease is the leading cause of death in patients with diabetes therefore prompt diagnosis and treatment of high risk groups is essential. Dobutamine stress echocardiography is a safe, cheap and reliable method for coronary artery disease diagnosis and provides important long term prognostic information. The diagnostic accuracy and prognostic power of this technique has been validated by a number of studies on patients with and without diabetes. This article discusses the application, interpretation, and accuracy of stress echocardiography both in the general population and in patients with diabetes. The role of advanced imaging modalites such as myocardial contrast agents and tissue Doppler imaging is also explored

Topics: Review
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2002). A step further in inter – institutional agreement in interpretation of dobutamine stress echocardiograms. Eur Heart J.
  2. Additional prognostic value of coronary fl ow reserve in diabetic and non diabetic patients with negative dipyridamole stress echocardiography by wall motion criteria.
  3. (1996). Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms.
  4. Application of tissue Doppler to interpretation of dobutamine echocardiography and comparison with quantitative coronary angiography.
  5. (1994). Coronary artery disease and coronary artery bypass grafting in diabetic patients aged 65 years (report from the Coronary Artery Surgery Study [CASS] Registry).
  6. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure.
  7. Depression of regional blood fl ow and wall thickening after brief coronary occlusion.
  8. Diabetes and cardiovascular risk factors: the Framingham study.
  9. (1993). Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care.
  10. (2005). Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant.
  11. (1992). Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography.
  12. Echocardiographic detection of coronary artery disease during dobutamine infusion.
  13. (2001). Effect of intravenous contrast for left ventricular opacifi cation and border defi nition on sensitivity and specifi city of dobutamine stress echocardiography compared with coronary angiography in technically diffi cult patients. Am Heart J.
  14. (1996). Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation.
  15. (1995). Improved cardiac risk stratifi cation in major vascular surgery with dobutamine-atropine stress echocardiography.
  16. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.
  17. (1998). Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
  18. Myocardial contrast echocardiography with power Doppler imaging.
  19. (1998). Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients.
  20. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease.
  21. Prognostic stratifi cation of diabetic patients by exercise echocardiography.
  22. Prognostic value of pharmacological stress echocardiography in diabetic patients.
  23. (1999). Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test.
  24. Quantifi cation of the spectrum of changes in regional myocardial function during acute ischemia in closed chest pigs: an ultrasonic strain rate and strain study.
  25. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women.
  26. (1991). Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes. Findings from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study.
  27. (1994). Risk stratifi cation for long-term outcome after elective coronary angioplasty: a multivariate analysis of 5,000 patients.
  28. (2006). Risk stratifi cation in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J.
  29. (1998). Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation.
  30. (1989). Role of myocardial oxygen consumption in dipyridamole-induced ischemia. Am Heart J.
  31. (1994). Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study.
  32. (2005). Screening for coronary artery disease in patients with diabetes: a Bayesian strategy of clinical risk evaluation and exercise echocardiography. Am Heart J.
  33. (1992). Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am Heart J.
  34. (1991). Stress echocardiography and the human factor: the importance of being expert.
  35. (1998). Stress echocardiography: recommendations for performance and interpretation of stress echocardiography.
  36. (2000). The comparable diagnostic accuracies of dobutamine-stress and dipyridamole-stress echocardiographies: a meta-analysis. Coron Artery Dis.
  37. (2007). The prevalence and prognosis of unrecognised myocardial infarction and silent myocardial ischaemia in patients undergoing major vascular surgery. Coron Artery Dis.
  38. (2002). Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care.
  39. Usefulness of harmonic imaging for left ventricular opacifi cation and endocardial border delineation by Optison.
  40. (1993). Value of dobutamine technetium-99m-sestamibi SPECT and echocardiography in the detection of coronary artery disease compared with coronary angiography.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.